Protagenic Therapeutics (PTIX) — Capital Reinvestment Ratio
Latest as of September 2008:
0.11x
Protagenic Therapeutics (PTIX) has a Capital Reinvestment Ratio of 0.11x as of September 2008, meaning it reinvests 0% of its operating cash flow ($6.90 Million) in capital expenditures ($765.00K). See Protagenic Therapeutics free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.11x
Capex / Operating Cash Flow
Operating Cash Flow
$6.90 Million
USD
Capital Expenditures
$765.00K
USD
Data as of
Sep 2008
Most recent filing
Protagenic Therapeutics Capital Reinvestment Ratio (1999–2008)
This chart tracks Protagenic Therapeutics's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Protagenic Therapeutics (1999–2008)
Year-by-year Capital Reinvestment Ratio for Protagenic Therapeutics from 1999 to 2008. For live market cap and broader valuation context, see market cap of Protagenic Therapeutics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.47x | $4.36 Million | $2.03 Million | ▲ +463.3% |
| 2006 | 0.08x | $931.00K | $77.00K | ▼ -89.5% |
| 2003 | 0.79x | $1.87 Million | $1.48 Million | ▲ +4.1% |
| 2002 | 0.76x | $2.35 Million | $1.78 Million | ▼ -69.8% |
| 2001 | 2.52x | $1.50 Million | $3.79 Million | ▲ +173.6% |
| 2000 | 0.92x | $3.51 Million | $3.23 Million | ▲ +276.3% |
| 1999 | 0.24x | $331.00K | $81.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow